Radiotherapy physics research in the UK: challenges and proposed solutions.

In 2011, the Clinical and Translational Radiotherapy Research Working Group (CTRad) of the National Cancer Research Institute brought together UK radiotherapy physics leaders for a think tank meeting. Following a format that CTRad had previously and successfully used with clinical oncologists, 23 departments were asked to complete a pre-meeting evaluation of their radiotherapy physics research infrastructure and the strengths, weaknesses, opportunities and threats within their own centre. These departments were brought together with the CTRad Executive Group and research funders to discuss the current state of radiotherapy physics research, perceived barriers and possible solutions. In this Commentary, we summarise the submitted materials, presentations and discussions from the meeting and propose an action plan. It is clear that there are challenges in both funding and staffing of radiotherapy physics research. Programme and project funding streams sometimes struggle to cater for physics-led work, and increased representation on research funding bodies would be valuable. Career paths for academic radiotherapy physicists need to be examined and an academic training route identified within Modernising Scientific Careers; the introduction of formal job plans may allow greater protection of research time, and should be considered. Improved access to research facilities, including research linear accelerators, would enhance research activity and pass on developments to patients more quickly; research infrastructure could be benchmarked against centres in the UK and abroad. UK National Health Service departments wishing to undertake radiotherapy research, with its attendant added value for patients, need to develop a strategy with their partner higher education institution, and collaboration between departments may provide enhanced opportunities for funded research.

[1]  R Jeraj,et al.  The physical basis and future of radiation therapy. , 2011, The British journal of radiology.

[2]  Emma Hall,et al.  Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial , 2011, The Lancet. Oncology.

[3]  W.P.M. Mayles Survey of the availability and use of advanced radiotherapy technology in the UK. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

[4]  R. Plummer,et al.  Radiotherapy research priorities for the UK. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

[5]  Brian O'Sullivan,et al.  Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Tim Maughan A new opportunity for radiotherapy research in the UK. , 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

[7]  J. Yarnold,et al.  The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial , 2008, The Lancet. Oncology.

[8]  J R Yarnold,et al.  The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial , 2008, The Lancet.

[9]  M. Parmar,et al.  Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. , 2007, The Lancet. Oncology.

[10]  T. Evans Best research for best health: a new national health research strategy. , 2006, Clinical medicine.

[11]  B. Slotman,et al.  Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  D. Dearnaley,et al.  Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial , 1999, The Lancet.

[13]  M. Parmar,et al.  Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial , 1997, The Lancet.

[14]  G. Kerr,et al.  Fast neutron treatment for squamous cell carcinoma of the head and neck: final report of Edinburgh randomised trial. , 1990, BMJ.

[15]  Annie Gao,et al.  Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial. , 2012, The Lancet. Oncology.

[16]  J. Yarnold,et al.  Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities. , 2011, International journal of radiation oncology, biology, physics.

[17]  J. Yarnold,et al.  Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.